Immunogenicity of COVID-19 mRNA vaccines in immunocompromised patients: a systematic review and meta-analysis
MM Mehrabi Nejad, F Moosaie… - European journal of …, 2022 - Springer
Background Immunocompromised (IC) patients are at higher risk of severe SARS-CoV-2
infection, morbidity, and mortality compared to the general population. They should be …
infection, morbidity, and mortality compared to the general population. They should be …
Antibiotic-resistant organisms establish reservoirs in new hospital built environments and are related to patient blood infection isolates
KV Sukhum, EP Newcomer, C Cass… - Communications …, 2022 - nature.com
Background Healthcare-associated infections due to antibiotic-resistant organisms pose an
acute and rising threat to critically ill and immunocompromised patients. To evaluate …
acute and rising threat to critically ill and immunocompromised patients. To evaluate …
Emerging challenges in the evaluation of fever in cancer patients at risk of febrile neutropenia in the era of COVID-19: a MASCC position paper
Patients with cancer are at higher risk of more severe COVID-19 infection and have more
associated complications. The position paper describes the management of cancer patients …
associated complications. The position paper describes the management of cancer patients …
Preexisting and post–COVID-19 immune responses to SARS-CoV-2 in patients with cancer
Patients with cancer, in particular patients with hematologic malignancies, are at increased
risk for critical illness upon COVID-19. We here assessed antibody as well as CD4+ and …
risk for critical illness upon COVID-19. We here assessed antibody as well as CD4+ and …
The role of inflammatory indices in the outcome of COVID-19 cancer patients
HA Nooh, MS Abdellateif, L Refaat, EZ Kandeel… - Medical Oncology, 2022 - Springer
To assess the prognostic role of different inflammatory indices on the outcome of cancer
patients with COVID-19. Sixty-two adults and 22 pediatric cancer patients with COVID-19 …
patients with COVID-19. Sixty-two adults and 22 pediatric cancer patients with COVID-19 …
Plasmonic nanohybrid with high photothermal conversion efficiency for simultaneously effective antibacterial/anticancer photothermal therapy
Plasmonic metal/semiconductor nanohybrids hold great promise in photocatalysis and
biosensor development; however, their potential phototherapeutic applications are yet fully …
biosensor development; however, their potential phototherapeutic applications are yet fully …
Safety and efficacy of pembrolizumab in combination with acalabrutinib in advanced head and neck squamous cell carcinoma: phase 2 proof-of-concept study
Abstract Purpose: Programmed cell death-1 (PD-1) receptor inhibitors have shown efficacy
in head and neck squamous cell carcinoma (HNSCC), but treatment failure or secondary …
in head and neck squamous cell carcinoma (HNSCC), but treatment failure or secondary …
Sample average treatment effect on the treated (SATT) analysis using counterfactual explanation identifies BMT and SARS-CoV-2 vaccination as protective risk factors …
Patients with multiple myeloma (MM), an age-dependent neoplasm of antibody-producing
plasma cells, have compromised immune systems and might be at increased risk for severe …
plasma cells, have compromised immune systems and might be at increased risk for severe …
Pneumococcal conjugate vaccine does not induce humoral response when administrated within the six months after CD19 CAR T-cell therapy
D Lee, AI Jordan, MA Menges, A Lazaryan… - … and Cellular Therapy, 2023 - Elsevier
CD19 targeted chimeric antigen receptor-modified T cell therapy (CAR-T) leads to B cell
aplasia and low serum immunoglobulin levels. Long-lived CD19–negative plasma cells may …
aplasia and low serum immunoglobulin levels. Long-lived CD19–negative plasma cells may …
Viral immunity and vaccines in hematologic malignancies: implications for COVID-19
MV Dhodapkar, KM Dhodapkar, R Ahmed - Blood cancer discovery, 2021 - AACR
Patients with hematologic malignancies have increased susceptibility to viral infections and
suboptimal immunologic responses to current vaccines due to both disease-associated and …
suboptimal immunologic responses to current vaccines due to both disease-associated and …